España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Valneva
VALN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Valneva (VALN) Forecast
News
Earnings
Valneva (VALN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Valneva (NASDAQ:VALN) Stock
Valneva Stock (NASDAQ: VALN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 30, 2025
Valneva USA Has Been Awarded A Maximum $49,29...
Benzinga Newsdesk
Thursday, January 23, 2025
HC Wainwright & Co. Maintains Buy on Valneva,...
Benzinga Newsdesk
Tuesday, January 21, 2025
Valneva shares are trading higher after the c...
Benzinga Newsdesk
Valneva Vaccine Shows Sustained Immune Response In Adolescents One Year After Single Shot
Vandana Singh
Reported Monday, Valneva Reports 98.3% Serore...
Benzinga Newsdesk
Thursday, December 19, 2024
Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Valneva Expands Chikungunya Vaccine Access In...
Benzinga Newsdesk
Wednesday, December 04, 2024
Valneva Unveils Key Insights On Chikungunya's...
Benzinga Newsdesk
Tuesday, December 03, 2024
Valneva's Chikungunya Shot Shows Strong, Long-Lasting Antibody Persistence At Three Years, Comparable In Older And Younger Adults
Vandana Singh
Valneva Reveals Three-Year Antibody Persisten...
Benzinga Newsdesk
Tuesday, November 26, 2024
Valneva Submits Label Extension Application F...
Benzinga Newsdesk
Friday, November 15, 2024
European And US Vaccine Stocks Are Under Pressure - Here's WHy
Vandana Singh
Thursday, November 07, 2024
Valneva Narrows Its 2024 Guidance: Now Expect...
Benzinga Newsdesk
Valneva's Revenue For Nine Months €116.637M U...
Benzinga Newsdesk
Wednesday, October 16, 2024
Valneva And LimmaTech Awarded FDA Fast Track ...
Benzinga Newsdesk
Friday, October 11, 2024
Palo Alto Networks To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
Expert Ratings For Valneva
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Valneva,...
Benzinga Newsdesk
Wednesday, September 25, 2024
In-Depth Examination Of 6 Analyst Recommendations For Valneva
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Valneva,...
Benzinga Newsdesk
Wednesday, September 18, 2024
Valneva Expands Chikungunya Vaccine Access, S...
Benzinga Newsdesk
Friday, September 13, 2024
Adobe, SelectQuote, Similarweb And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Tuesday, September 03, 2024
Pfizer And Valneva Partnered Lyme Disease Vaccine Shows Effectiveness As Booster Shot In Mid-Stage Study
Vandana Singh
The Analyst Landscape: 6 Takes On Valneva
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Valneva...
Benzinga Newsdesk
Valneva And Pfizer Announced Further Immunoge...
Benzinga Newsdesk
Monday, August 19, 2024
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Wednesday, August 14, 2024
Analyst Scoreboard: 8 Ratings For Valneva
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Valneva...
Benzinga Newsdesk
Tuesday, August 13, 2024
Valneva shares are trading higher. The compan...
Benzinga Newsdesk
Valneva Reaffirmed Its 2024 Guidance: Expects...
Benzinga Newsdesk
Valneva H1 Revenue €70.8M Down From €73.7M Yo...
Benzinga Newsdesk
Friday, August 02, 2024
HC Wainwright & Co. Reiterates Buy on Valneva...
Benzinga Newsdesk
Thursday, August 01, 2024
Valneva And LimmaTech Forge Strategic Partner...
Benzinga Newsdesk
Monday, July 22, 2024
What Analysts Are Saying About Valneva Stock
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Valneva...
Benzinga Newsdesk
CEPI And EU Grant Valneva $41.3M To Enhance G...
Benzinga Newsdesk
Thursday, July 18, 2024
Pfizer/Valneva's Vaccine Study For Tick-Borne Infection Completes Primary Vaccination Series, Plans Approval In 2026
Vandana Singh
Wednesday, July 17, 2024
Pfizer And Valneva Announce Primary Vaccinati...
Benzinga Newsdesk
Monday, July 01, 2024
Valneva shares are trading higher after the c...
Benzinga Newsdesk
The European Commission Has Granted Marketing...
Benzinga Newsdesk
Friday, June 28, 2024
HC Wainwright & Co. Reiterates Buy on Valneva...
Benzinga Newsdesk
Monday, June 24, 2024
The Analyst Landscape: 6 Takes On Valneva
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Valneva...
Benzinga Newsdesk
Tuesday, June 04, 2024
HC Wainwright & Co. Reiterates Buy on Valneva...
Benzinga Newsdesk
Monday, June 03, 2024
Valneva Announces Phase 2 Trials Of Lyme Dise...
Benzinga Newsdesk
Friday, May 31, 2024
Valneva Receives Positive CHMP Opinion From E...
Benzinga Newsdesk
What Analysts Are Saying About Valneva Stock
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Valneva...
Benzinga Newsdesk
Show More
